Abstract #3969
Chemical Exchange Saturation Transfer (CEST) Imaging for Thoracic Oncology: Preliminary Experience for Characterization of Thoracic Nodule and Mass
Yoshiharu Ohno 1,2 , Masao Yui 3 , Cheng Ouyang 4 , Mitsue Miyazaki 4 , Hisanobu Koyama 5 , Shinichiro Seki 5 , Katsusuke Kyotani 6 , Yoshiko Ueno 5 , Takeshi Yoshikawa 1,2 , Sumiaki Matsumoto 1,2 , and Kazuro Sugimura 5
1
Advanced Biomedical Imaging Research, Kobe
University Graduate School of Medicine, Kobe, Hyogo,
Japan,
2
Division
of Functional and Diagnostic Imaging Research,
Department of Radiology, Kobe University Graduate School
of Medicine, Kobe, Hyogo, Japan,
3
Toshiba
Medical Systems Corporation, Tochigi, Japan,
4
Toshiba
Medical Research Institute USA, IL, United States,
5
Division
of Radiology, Department of Radiology, Kobe University
Graduate School of Medicine, Kobe, Hyogo, Japan,
6
Center
for Radiology and Radiation Oncology, Kobe University
Hospital, KObe, Hyogo, Japan
Chemical exchange saturation transfer (CEST) imaging is
suggested as new technique and one of the MR-based
molecular imaging techniques. However, no major reports
have been published for evaluating clinical utility of
CEST imaging in thoracic oncology patients. We
hypothesized that newly developed CEST imaging is
possible to evaluate thoracic nodule and mass, and play
as new diagnostic tool in routine clinical practice. The
purpose of this study was to determine the capability of
CEST imaging for characterization of thoracic nodule and
mass, and evaluate a potential as a new MR-based
molecular imaging method in thoracic oncology.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
